Celltrion Healthcare
Scope
Date
~
-
Pension funds
POBA targets PE in tech, bio, healthcare in long term, CIO says
Public Officials Benefit Association (POBA) of South Korea will keep its focus on steady cash flow while strengthening profitability, its Chief Inve...
May 09, 2022 (Gmt+09:00)
-
Bio & Pharma
Boryung takes 'health is wealth' to whole new level – space
South Korean biotech and pharmaceutical companies are expanding their footholds in the global space medicine market. Boryung, formerly Boryung Pharm...
Apr 20, 2022 (Gmt+09:00)
-
Healthcare
KT taps Vietnam for digital healthcare and AI-powered diagnosis
KT Corp., a major telecommunications company in South Korea, is set to enter the Vietnamese healthcare market with a pilot telemedicine service an...
Apr 13, 2022 (Gmt+09:00)
-
Korean Investors
Healthcare, tech top Korean LPs' favorite PE sectors
Healthcare and technology are the preferred sectors for global private equity investment, a survey of South Korea's major asset owners has shown. Co-i...
Apr 06, 2022 (Gmt+09:00)
-
Korean Investors
Healthcare, tech top Korean LPs' favorite PE sectors
Healthcare and technology are the preferred sectors for global private equity investment, a survey of South Korea's major asset owners has shown. Co-i...
Apr 06, 2022 (Gmt+09:00)
-
Healthcare
EDGC enters US procurement market with medical supplies
Eone Diagnomics Genome Center Co. (EDGC), a South Korean healthcare firm specializing in genetic analysis technology, is set to enter the US governm...
Mar 31, 2022 (Gmt+09:00)
-
Healthcare
LG Elec. targets North American digital healthcare market
South Korea’s LG Electronics Inc. has made inroads into the North American digital healthcare market with US telehealth company Amwell as the ...
Mar 21, 2022 (Gmt+09:00)
language -
Bio & Pharma
Korean bio ventures struggle with fundraising
Biopharmaceutical companies of South Korea are having a tough time fundraising of late. Bio ventures without specific public offering plans are pa...
Mar 01, 2022 (Gmt+09:00)
-
Venture capital
Live commerce platforms like Grip to keep growing in Asia Pacific: Google
In April 2021, there were some 200 unicorns in the Asia Pacific region, second only to the United States which had 290 startups each valued at $1 bi...
Feb 22, 2022 (Gmt+09:00)
-
Pharmaceuticals
Celltrion, Humasis to ship $300 mn COVID-19 test kits to US
South Korea's biopharmaceutical company Celltrion Inc. and diagnostic kit manufacturer Humasis Co. have signed contracts to supply their jointly-dev...
Feb 04, 2022 (Gmt+09:00)
-
Korean stock market
EcoPro BM beats Kosdaq's top market cap Celltrion
EcoPro BM Co., a leading manufacturer of cathode material for secondary batteries, topped the market capitalization for Kosdaq-listed firms on Jan...
Jan 19, 2022 (Gmt+09:00)
language -
Korean startups
SK Networks invests in AI-based US healthcare startup LVIS
South Korea’s SK Networks Co. said on Tuesday it joined a $15 million in Series B-2 funding for US healthcare startup LVIS Corp.LVIS, headquar...
Jan 11, 2022 (Gmt+09:00)
-
Sovereign wealth funds
KIC eyes tech, healthcare, telecoms via PE and VC
Korea Investment Corporation (KIC) aims to increase alternative investment to 25% of its total investment by 2025 as well as rank among the world's ...
Jan 05, 2022 (Gmt+09:00)
-
Pharamaceuticals, biotech
Celltrion to conduct tests on Omicron variant detected in Korea
Biopharmaceutical powerhouse Celltrion Inc. plans to use its treatments to test the Omicron variant detected in Korea, according to a high-level com...
Dec 06, 2021 (Gmt+09:00)
-
Tech, Media & Telecom
Kakao extends rivalry with Naver into digital healthcare
Kakao Corp., an operator of South Korea's top mobile messenger app KakaoTalk, has set its sights on the digital healthcare market, launching an in-h...
Dec 03, 2021 (Gmt+09:00)
-
COVID-19
Celltrion to export COVID-19 treatment to Europe in 2021
South Korea’s pharmaceutical giant Celltrion Inc. is set to export its COVID-19 treatment Regkirona to Europe by the end of this year as it se...
Nov 30, 2021 (Gmt+09:00)
language -
Biotech
Celltrion looks beyond biosimilars to develop its own mRNA drugs
South Korea’s Celltrion Inc. has long been a biosimilar player, producing replicas of original drugs, a growing market in the pandemic era.Ear...
Nov 16, 2021 (Gmt+09:00)
-
COVID-19
Celltrion wins COVID-19 treatment approval from Europe
South Korea’s pharmaceutical giant Celltrion Inc. has won final approval for its COVID-19 treatment Regkirona from the European Commission, a ...
Nov 15, 2021 (Gmt+09:00)
language -
ASK 2021
KIC to raise alternative investments to 25% by 2027
Korea Investment Corp. (KIC) plans to increase alternative investments to a quarter of its portfolio by 2027 from the current 16%, its CEO Jin Seoun...
Oct 27, 2021 (Gmt+09:00)
-
Healthcare
InBody to expand into household, blood pressure monitoring markets
South Korea’s InBody Co., the global market leader of body composition analyzer devices, will be making a strategic turn to focus on the fast-...
Oct 06, 2021 (Gmt+09:00)
-
Corporate governance
Celltrion makes first step in streamlining governance structure
South Korea’s pharmaceutical conglomerate Celltrion Group has made its very first step in reforming corporate governance structure by merging ...
Sep 17, 2021 (Gmt+09:00)
language -
Pharmaceuticals
High-priced drugs add to pressure for Korea's healthcare reform
A number of new rare disease treatments, approved in South Korea over the past year, are still unaffordable for the public because of their price ta...
Sep 15, 2021 (Gmt+09:00)
-
M&As
Lotte teams up with IMM PE to acquire furniture maker Hanssem
Lotte Group is seeking to acquire a stake in Hanssem Co., South Korea’s largest furniture and home furnishing company, with an investment of u...
Sep 01, 2021 (Gmt+09:00)
language -
Digital healthcare
Naver to enter healthcare business in Korea with investment in ezCaretech
South Korea’s online platform giant Naver Corp. is set to enter the big data-based healthcare industry by investing in ezCaretech Co., a domes...
Aug 25, 2021 (Gmt+09:00)
-
Covid-19 treatment
Brazil gives emergency use nod for Celltrion’s COVID-19 treatment
South Korean drugmaker Celltrion Inc. has added Brazil to the list of countries that have granted emergency use approval for its COVID-19 treatment ...
Aug 13, 2021 (Gmt+09:00)
language -
COVID-19
Celltrion to enter clinical trials of new COVID-19 treatment
South Korean biosimilar maker Celltrion Inc. will launch the first-phase clinical trials of its new COVID-19 treatment candidate next month, followi...
Aug 05, 2021 (Gmt+09:00)
language -
Future Mobility
Hyundai Mobis targets in-vehicle healthcare with brainwave technology
South Korea’s top auto parts maker Hyundai Mobis has developed a new brainwave detection technology that monitors a driver's physical and psyc...
Jul 21, 2021 (Gmt+09:00)
language -
Covid-19 treatment
Indonesia grants emergency use approval for Celltrion’s COVID-19 treatment
South Korean drugmaker Celltrion Inc. has received the Indonesian government’s permission for restricted use of its COVID-19 treatment Regkiro...
Jul 20, 2021 (Gmt+09:00)
-
COVID-19
Celltrion’s COVID-19 treatment reduces incidence of severity by 70%
Celltrion Inc. on July 13 said that its COVID-19 treatment Regkirona has proven effective in reducing the incidence of severe cases of the virus by ...
Jul 13, 2021 (Gmt+09:00)
language -
Biosimilars
Celltrion, Samsung Bioepis anticipate increased biosimilar sales in Europe
South Korean biosimilar companies such as Celltrion Inc. and Samsung Bioepis Co. are likely to see their sales hike by tens of millions of dollars...
Jul 12, 2021 (Gmt+09:00)